DR. MARTIN L MAYSE, MD
Osteopathic Medicine at Childrens Pl, Saint Louis, MO
License number
Missouri 2003018930
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
4960 Childrens Pl, Saint Louis, MO 63110
Phone
(314) 454-8917
(314) 454-5571 (Fax)
(314) 454-5571 (Fax)
Personal information
See more information about MARTIN L MAYSE at radaris.comName
Address
Phone
7360 Teasdale Ave, Saint Louis, MO 63130
Professional information
Chief Technology Officer At Holaira, Inc.
Position:
Chief Technology Officer at Holaira, Inc.
Location:
Greater St. Louis Area
Industry:
Medical Devices
Work:
Holaira, Inc.
- Greater Minneapolis-St. Paul Area since Feb 2013
-
Chief Technology Officer
Innovative Pulmonary Solutions, Inc.
Jun 2008 - Feb 2013
-
Chief Medical Officer
Calypso Medical
Mar 2004 - 2011
-
Consultant
Washington University School of Medicine
Aug 2003 - Mar 2009
-
Director of Interventional Pulmonology
Tulane University
Jul 2002 - Jul 2003
-
Instructor of Medicine
Yale University
Jul 1999 - Jun 2002
-
Fellow, Pulmonary and Critical Care Medicine
Yale New Haven Hospital
Jul 1996 - Jun 1999
-
Resident, Medicine
Education:
Yale University School of Medicine 1991 - 1996
M.D., Medicine Wright State University 1988 - 1990
Wright State University 1985 - 1988
BSE, Biomedical Engineering
M.D., Medicine Wright State University 1988 - 1990
Wright State University 1985 - 1988
BSE, Biomedical Engineering
Skills:
Pulmonology, Medicine, Critical Care Medicine, Board Certified, Internal Medicine, Medical Device R&D, Intellectual Property
Martin L Mayse, Saint Louis MO
Specialties:
Pulmonologist
Address:
4960 Childrens Pl, Saint Louis, MO 63110
Education:
Doctor of Medicine*
Board certifications:
American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)*
Dr. Martin L Mayse, Saint Louis MO - MD (Doctor of Medicine)
Specialties:
Pulmonology
Address:
4921 Parkview Pl SUITE 8B, Saint Louis 63110
(314) 454-8917 (Phone), (314) 454-8768 (Fax)
(314) 454-8917 (Phone), (314) 454-8768 (Fax)
Certifications:
Internal Medicine, 2002, Pulmonary Disease, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Yale University
Graduated: 1995
Yale University
Graduated: 1995
Thoracentesis Catheter System With Self-Sealing Valve
US Patent:
2007028, Dec 6, 2007
Filed:
May 31, 2006
Appl. No.:
11/446086
Inventors:
Martin L. Mayse - University City MO, US
International Classification:
A61M 5/178
US Classification:
60416401, 60416402, 60416703
Abstract:
The present invention provides thoracentesis systems composed of an insertion needle, a thoracentesis catheter with self-sealing valve, and a valve opening device which are utilized in the removal of fluid or gases from a pleural cavity. The insertion needle is utilized to insert the thoracentesis catheter into the pleural cavity. The thoracentesis catheter provides automatic closure of the flow path from the pleural cavity by automatic closure of the self-sealing valve upon removal of the insertion needle from the thoracentesis catheter. The self-sealing valve prevents drainage of fluid from the pleural cavity and introduction of air into the pleural cavity when the needle is withdrawn from the thoracentesis catheter and a valve opening device is not in place. A drainage flow path from the pleural cavity is established by insertion of a valve opening device into the self-sealing valve of the thoracentesis catheter, thus opening the self-sealing valve. With the self-sealing valve opened by a valve opening device, fluid or gases can be removed from the pleural cavity.
Non-Invasive And Minimally Invasive Denervation Methods And Systems For Performing The Same
US Patent:
2011011, May 19, 2011
Filed:
Nov 11, 2010
Appl. No.:
12/944666
Inventors:
Martin L. Mayse - University City MO, US
Steven C. Dimmer - Bellevue WA, US
Steven C. Dimmer - Bellevue WA, US
International Classification:
A61B 18/04, A61N 7/00
US Classification:
606 33, 601 2, 606 27
Abstract:
A system and method can be used to denervate at least a portion of a bronchial tree. An energy emitter of an instrument is percutaneously delivered to a treatment site and outputs energy to damage nerve tissue of the bronchial tree. The denervation procedure can be performed without damaging non-targeted tissue. Minimally invasive methods can be used to open airways to improve lung function in subjects with COPD, asthma, or the like. Different sections of the bronchial tree can be denervated while leaving airways intact to reduce recovery times.
Tapered Attachment For Pleural Catheter
US Patent:
2007007, Apr 5, 2007
Filed:
Aug 23, 2006
Appl. No.:
11/466604
Inventors:
Martin Mayse - University City MO, US
International Classification:
A61M 39/00
US Classification:
604533000
Abstract:
The present invention is a tapered attachment for use with a pleural catheter that connects securely to the pleural catheter and has a hollow elongated member and a tapered distal portion. When the tapered attachment connected to the prior art catheter, the hollow elongated member opens the self-sealing valve of the prior art catheter allowing communication from the interior of the pleural catheter to the interior of the tapered attachment. The distal outer taper of the invention can connect to a variety of standard drainage systems to remove fluids or gases from the pleural cavity. The invention may also have a one way valve. With the invention in place and functioning, air does not enter the pleural space. Additionally, the variations in pleural pressure that normally occur during respiration can pump fluids or gases out of the pleural cavity through the invention.
Device And Method For Esophageal Cooling
US Patent:
2007005, Mar 8, 2007
Filed:
Sep 1, 2006
Appl. No.:
11/469749
Inventors:
MARTIN MAYSE - University City MO, US
James Hummel - East Haven CT, US
James Hummel - East Haven CT, US
International Classification:
A61F 7/00, A61F 7/12
US Classification:
607105000, 607113000
Abstract:
The present invention includes a device and a method for preventing injury of the esophagus during thermal ablation of the left atrium. The device has an esophageal probe with a balloon tip for insertion into the esophagus of a patient. During usage, coolant passes into the esophageal probe and then fills its balloon. The coolant, when circulating through the balloon and an external cooling machine, protects the esophageal tissue in contact with the esophageal probe from thermal damage during ablation of the posterior wall of the left atrium of the heart, or other procedure.
Delivery Devices With Coolable Energy Emitting Assemblies
US Patent:
2012001, Jan 19, 2012
Filed:
Sep 26, 2011
Appl. No.:
13/245537
Inventors:
Martin L. Mayse - University City MO, US
Steven C. Dimmer - Bellevue WA, US
Steven C. Dimmer - Bellevue WA, US
Assignee:
Innovative Pulmonary Solutions, Inc. - Bellevue WA
International Classification:
A61B 18/14, A61B 18/12
US Classification:
606 41
Abstract:
Systems, delivery devices, and methods to treat to ablate, damage, or otherwise affect tissue. The treatment systems are capable of delivering a coolable ablation assembly that ablates targeted tissue without damaging non-targeted tissue. The coolable ablation assembly damages nerve tissue to temporarily or permanently decrease nervous system input.
Systems, Assemblies, And Methods For Treating A Bronchial Tree
US Patent:
2012031, Dec 13, 2012
Filed:
Aug 13, 2012
Appl. No.:
13/584142
Inventors:
Martin L. Mayse - University City MO, US
Steven C. Dimmer - Bellevue WA, US
Steven C. Dimmer - Bellevue WA, US
Assignee:
INNOVATIVE PULMONARY SOLUTIONS, INC. - Bellevue WA
International Classification:
A61B 18/18
US Classification:
606 33
Abstract:
Systems, assemblies, and methods to treat pulmonary diseases are used to decrease nervous system input to distal regions of the bronchial tree within the lungs. Treatment systems damage nerve tissue to temporarily or permanently decrease nervous system input. The treatment systems are capable of heating nerve tissue, cooling the nerve tissue, delivering a flowable substance that cause trauma to the nerve tissue, puncturing the nerve tissue, tearing the nerve tissue, cutting the nerve tissue, applying pressure to the nerve tissue, applying ultrasound to the nerve tissue, applying ionizing radiation to the nerve tissue, disrupting cell membranes of nerve tissue with electrical energy, or delivering long acting nerve blocking chemicals to the nerve tissue.
Delivery Devices With Coolable Energy Emitting Assemblies
US Patent:
2012001, Jan 19, 2012
Filed:
Sep 26, 2011
Appl. No.:
13/245529
Inventors:
Martin L. Mayse - University City MO, US
Steven C. Dimmer - Bellevue WA, US
Steven C. Dimmer - Bellevue WA, US
Assignee:
Innovative Pulmonary Solutions, Inc. - Bellevue WA
International Classification:
A61B 18/14
US Classification:
606 41
Abstract:
Systems, delivery devices, and methods to treat to ablate, damage, or otherwise affect tissue. The treatment systems are capable of delivering a coolable ablation assembly that ablates targeted tissue without damaging non-targeted tissue. The coolable ablation assembly damages nerve tissue to temporarily or permanently decrease nervous system input.